Pionyr raises $62M series B

On Dec. 13, Pionyr Immunotherapeutics Inc. (San Francisco, Calif.) raised $62 million in a series B round led by New Enterprise Associates. Fellow new investors Sofinnova Ventures and Vida Ventures also participated, as did existing investors OrbiMed, SV Health Investors, Osage University Partners and Mission Bay Ventures.

Since its founding in 2015, Pionyr has now raised a total of $72 million...